91±¬ÁÏ

April 13

Rebecca Crews opens up about Parkinson’s treatment breakthrough

91±¬ÁÏ senior medical analyst Dr. Marc Siegel discusses Rebecca Crews’ experience with a new Parkinson’s treatment and efforts to raise awareness about the disease on ‘Fox & Friends.’

April 12

Early Parkinson’s symptoms misdiagnosed for years, Terry Crews’ wife reveals

Terry Crews' wife Rebecca King Crews reveals her Parkinson's disease diagnosis and shares how a new non-invasive brain procedure eased her symptoms. Experts discuss the early-onset condition.

April 9

Common vaccine slashes Alzheimer's disease risk when dose is increased

A new study suggests a high-dose flu shot may cut Alzheimer's risk by nearly half in older adults, far outperforming the standard-dose vaccine version.

April 7

Man with Celine Dion's rare disease warns her comeback could be dangerous

A former marathon runner who was himself diagnosed with stiff-person syndrome says Celine Dion's comeback tour could be a trigger for the rare condition.

April 7

Super Bowl champion Steve McMichael, who died last year, revealed to have CTE

Pro Football Hall of Famer Steve McMichael, who died after battling ALS for five years, has been posthumously diagnosed with stage 3 CTE.

April 7

Experts reveal hidden link between poor sleep and Alzheimer's disease risk

A new study links tau pathology to disrupted sleep in Alzheimer's disease. Sleep expert Dr. Wendy Troxel discusses how critical sleep is for brain health.

April 6

Terry Crews' wife reveals she battled Parkinson's in secret for years before finding hope in new treatment

Rebecca King Crews opens up on the "Today Show" about living with Parkinson's disease for 16 years and how a newly approved procedure is helping her.

April 5

5 key factors may predict stroke risk years after first event, study finds

New research reveals five factors that may predict another stroke after a mini stroke, including hypertension, smoking and three specific stroke subtypes.

April 3

Breakthrough ALS study launches as drug aims to slow disease progression

The PREVAiLS study, believed to be the only recruiting phase 3 ALS trial, aims to slow disease progression and preserve function in early-stage patients.

March 27

Common medical condition seen years before dementia develops, study reveals

A new study links cystitis and bacterial infections to a 19% higher rate of late-onset dementia, suggesting severe infections may accelerate cognitive decline.